Inhibiting SARS‐CoV‐2 infection with lysosomal alkalizers

Understanding the SARS‐CoV‐2 virus’ routes of infection, virus–host–protein interactions, and mechanisms of virus‐induced cytopathic effects will greatly aid in the discovery and design of new therapeutics to treat COVID‐19. Chloroquine and hydroxychloroquine, extensively explored as clinical agents...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:FASEB J
Asıl Yazarlar: Gorshkov, Kirill, Chen, Catherine, Bostwick, Robert, Rasmussen, Lynn, Tran, Bruce, Cheng, Yu‐Shan, Xu, Miao, Pradhan, Manisha, Henderson, Mark, Zhu, Wei, Oh, Eunkeu, Susumu, Kimihiro, Wolak, Mason, Shamim, Khalida, Huang, Wenwei, Hu, Xin, Shen, Min, Klumpp‐Thomas, Carleen, Itkin, Zina, Shinn, Paul, de la Torre, Juan Carlos, Simeonov, Anton, Michael, Samuel, Hall, Matthew, Lo, Donald, Zheng, Wei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Federation of American Societies for Experimental Biology 2021
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239884/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fasebj.2021.35.S1.02122
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller